Cognition Therapeutics CGTX
NASDAQ CGTX
$0.67 -0.02 (-2.95%)
At close: Nov 10, 2026 · 4:00 PM EST

Cognition Therapeutics (CGTX) Debt Ratio (2020)

Updated

Cognition Therapeutics' Debt Ratio came in at 0.06 for Q4 2020.

Analysis

Cognition Therapeutics (CGTX) Debt Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 0.33
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.23
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 0.55
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 0.41
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 0.08
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 0.28
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 0.56
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 0.51
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.31
10 Cognition Therapeutics 61.77 Mn -79.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 0.06
API Access

Cognition Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CGTX&period=max&api_key=YOUR_API_KEY